Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
分解 G1 療法：5 位分析師分享他們的觀點
In the preceding three months, 5 analysts have released ratings for G1 Therapeutics (NASDAQ:GTHX), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師發佈了G1 Therapeutics（納斯達克股票代碼：GTHX）的評級，提出了從看漲到看跌的各種觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $10.8, along with a high estimate of $14.00 and a low estimate of $4.00. Surpassing the previous average price target of $9.50, the current average has increased by 13.68%.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲10.8美元，最高估計爲14.00美元，低估值爲4.00美元。超過了之前的平均目標股價9.50美元，目前的平均價格上漲了13.68％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
An in-depth analysis of recent...
對分析師近期...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。